, many of which are similar to mice with maternal and paternal uniparental disomies of the distal chromosome 2 region to which Gnas maps, respectively (18, 19) . (Uniparental disomy is the inheritance of both copies of a chromosome or subchromosomal region from a single parent). The +/p-mice are smaller than normal at birth, fail to suckle, and most die within several hours probably as a result of severe hypoglycemia. In contrast, m-/+ are larger than normal at birth and most die 1-3 weeks after birth. These distinct phenotypes are presumably due to the fact that Gnas is an imprinted gene. An interesting difference between the m-/+ and +/p-mice that survive past weaning (∼20-25% of each group) is their opposite changes in fat mass, with increased and decreased fat accumulation in adipose tissue of m-/+ and +/p-mice, respectively. In this report, we characterize these phenotypes in detail and show that these changes are associated with decreased and increased energy metabolism in m-/+ and +/p-mice, respectively.
Methods
Mice. Mice with insertion of a neomycin resistance cassette into exon 2 of Gnas were previously created by targeted mutagenesis (8) . Female heterozygotes were mated to wild-type CD-1 males (Charles River Laboratories, Wilmington, Massachusetts, USA), and male heterozygotes were mated to wild-type CD-1 females to generate m-/+ and +/p-mice, respectively. Animals were maintained on a 12-hour light/dark cycle (0600/1800 hours) and standard pellet diet (NIH-07, 5% fat by weight; Zeigler Brothers Inc., Gardners, Pennsylvania, USA) and studied at 21-25°C unless noted otherwise. In all studies, m-/+ and +/p-mice were studied along with sex-matched wild-type littermates (designated m+/+ and +/p+, respectively), and statistical significance was determined using an unpaired t test.
Blood and tissue analysis. Serum triglycerides and cholesterol were determined by Ani-Lytics, Inc. (Gaithersburg, Maryland, USA). Serum thyrotropin (TSH) was measured by double antibody RIA (National Hormone and Pituitary Program of the National Institute of Diabetes, Digestive, and Kidney Diseases, National Institutes of Health [NIH] , Torrance, California, USA). Thyroid hormones were measured by RIA (NIH Clinical Pathology Department). Leptin was measured by RIA using a commercial kit (Linco Research, St. Charles, Missouri, USA). For histological examinations, tissues were fixed in 10% neutral buffered formalin (4% formaldehyde; Sigma Chemical Co., St. Louis, Missouri, USA), paraffin-embedded, and sections were stained with hematoxylin and eosin.
Food intake studies. Six-week-old male mice were individually caged, and rodent chow was weighed and placed in the bottom of each cage without bedding. Remaining food was weighed 3 and 7 days later. Within each group, there was no difference in the rate of food intake between days 1-3, 3-7, or 1-7.
Indirect calorimetry and in vivo responsiveness to β 3 -adrenergic stimulation. Oxygen consumption was measured using a 4-chamber Oxymax system (Columbus Instruments, Columbus, Ohio, USA; 2.5 L chambers with wire mesh floors, using 1 L/min flow rate, 75-second purge, and 60-second measure), with 1 mouse per chamber. Motor activity (total and ambulating) was determined by infrared beam interruption (Opto-Varimex mini; Columbus Instruments). Resting oxygen consumption was calculated as the average of the points with less than 6 ambulating beam breaks per minute.
The effect of the β 3 -specific adrenergic agonist CL316243 (20) was measured as follows, with each mouse serving as its own control. At approximately 0900 hours, mice were placed into the calorimetry chambers, which were prewarmed to 30°C, and baseline data were collected. Three hours later, CL316243 was injected intraperitoneally at the indicated dose (from a 1 mg/mL stock in saline), and, after a 1 hour delay, data were collected for 2 hours. Food and water were available at all times.
To measure the response of serum glycerol and FFAs to β 3 -adrenergic stimulation, a maximal dose of CL316243 (1,000 µg/kg intraperitoneally) was administered at 1400 hours to 8-week-old male mice that were fasted for 6 hours. Blood was collected from their tail vein before and after injection, and serum glycerol (no. 339-11; Sigma Chemical Co.) and FFA (no. 1383175; Boehringer Mannheim) were measured.
Measurement of urinary catecholamines and metabolites. Mice were placed individually in mouse metabolic cages (Nalgene; Nalge Nunc Internationsl, Rochester, New York, USA) for 3 days of acclimatization, and then urine was collected over the next 3 days. Urine pH was maintained ≤3 with HCl; urine volume was measured; and aliquots were frozen at -70°C. Food and water were provided ad libitum throughout the collection. Urine catecholamines and their metabolites were measured by HPLC (21) . Urine creatinine concentration was measured using the Cobas Mira analyzer (Roche Diagnostic Systems, Branchburg, New Jersey, USA).
Northern analysis. Total RNA was isolated from tissues by the TRIZol method (GIBCO BRL), Rockville, Maryland, USA). Rat uncoupling protein 1 (UCP1) (22) , mouse UCP3 (23) , and mouse G s α (coding region nucleotides 1-125; ref. 24) probes were labeled with 32 P by random priming. Northern analysis was performed as described previously (25) , using 15 µg total RNA per lane except that the hybridization temperature was 45°C for the UCP1 probe and 42°C for the UCP3 probe and the final wash temperature was 55°C for the G s α probe. To normalize for loading differences, 28S ribosomal RNA was stained with ethidium bromide and quantified using Gel Expert software (NucleoTech Corp., San Mateo, California, USA).
Membrane preparation and immunoblot analysis. To prepare total membranes from brown adipose tissue (BAT), the tissue was homogenized in ice-cold membrane buffer (0. 25 with a Teflon pestle and centrifuged at 250 g for 10 minutes at 20°C. The supernatant was recentrifuged at 436,000 g in a TLA100.3 rotor (Beckman Instruments Inc., Fullerton, California, USA) for 30 minutes at 4°C, and the membrane pellet was resuspended in membrane buffer and stored at -70°C. Protein concentrations were determined using the BCA kit (Pierce Chemical Co., Rockford, Illinois, USA). Immunoblotting using a G s α-specific antibody was performed as described previously (8) . To normalize for loading differences, relative amounts of protein in each sample was determined by Coomassie blue staining and quantification with Gel Expert software.
Results
Maternal versus paternal inheritance of a G s α knockout allele leads to opposite effects on lipid metabolism. Within days after birth, m-/+ and +/p-mice can be distinguished by their body habitus. The +/pmice are very thin, whereas m-/+ mice tend toward obesity. At weaning (∼22 days) both m-/+ and +/p-mice weighed less than their littermates (Figure 1) , reflecting delayed development in both groups of mutant mice (8) . Over the next 3 weeks, m-/+ mice gained weight significantly faster than their wild-type littermates, while +/p-mice remained underweight. Because body mass index (BMI) is inversely proportional to the square of the length, and the length of both m-/+ and +/p-mice averaged approximately 90% of wild-type (Table 1) , a relative weight of approximately 80% (rather than 100%) reflects a BMI equivalent to that of wild-type mice. By day 60, all +/p-mice still weighed less than 80% of their littermates, whereas m-/+ mice weighed more than 80% (with many greater than 100%) of their littermates. Males and females had similar relative weight curves for both groups. Serum triglycerides and cholesterol tended to be lower in m-/+ mice and were significantly reduced in +/p-mice (Table 2) .
At birth, interscapular BAT had a similar gross and microscopic appearance in m-/+, +/p-, and wild-type mice (data not shown). Over the next 2 days, m-/+ and +/p-mice showed drastic and opposite changes in BAT lipid accumulation. The interscapular BAT pads in +/p-mice were smaller and more brown than those in wild-type mice, whereas in m-/+, mice they were larger and lighter in color. Figure 2a ). These opposite effects on BAT and WAT fat pad mass were maintained throughout the adult period (Table 1) . Taken together, these data suggest that BAT is more active in +/p-mice and less active in m-/+ mice when compared with littermate controls.
Uncoupling proteins are mitochondrial proteins that uncouple substrate oxidation from the generation of ATP, leading to energy dissipation as heat (26, 27) . UCP1 is expressed only in BAT and is positively regulated by sympathetic (β-adrenergic) stimulation, which also increases metabolic activity (26) (27) (28) . Typically, BAT histology correlates with UCP1 mRNA levels. Histologically, BAT in +/p-mice appears more metabolically active, whereas BAT in m-/+ mice appears less metabolically active. Consistent with this, UCP1 mRNA expression in BAT tended to be increased in +/p-mice and decreased in m-/+ mice ( Figure 2b) . Expression of the uncoupling protein UCP3 in BAT of +/p-and m-/+ mice was similar to that of wild-type ( Figure 2b ). Mus- Table 3 ). By 60 days, all m-/+ mice weighed greater than 80% of wild-type, whereas all +/p-mice weighed less than 80% of wild-type. C 11.4 ± 0.1 (13) (10) 76 ± 15 (10) B 271 ± 63 (7) 631 ± 166 (7) E A Measurements of +/p-and m-/+ mice (4-to 8-month old) and wild-type littermates (+/p+ and m+/+, respectively) expressed as mean ± SEM (n). B P < 0.05 versus wild-type littermates. C Length measured from tip of nose to anus. D BMI is total body weight (g) divided by the square of the nasoanal length (cm). E P = 0.065 versus wild-type littermates.
cle UCP3 expression was also unaffected (+/p-mice: 100 ± 9% of wild-type, n = 5 pairs; m-/+ mice: 97 ± 10% of wild-type, n = 5 pairs). Thyroid hormone is a major regulator of basal metabolic rate, and patients with PHP Ia who have mutations in the maternal allele of the human homolog GNAS1 are hypothyroid due to TSH resistance (3). However, there were no differences in serum TSH, triiodothyronine (T3), or thyroxine (T4) between +/p-, m-/+, and wild-type mice (Table 2) . Therefore the differences in fat accumulation are not due to differences in activity of the thyroid axis. These results are consistent with the fact that there were no differences in UCP3 expression (see earlier discussion here), as UCP3 expression is known to be regulated by thyroid hormone (22) .
Leptin is a circulating hormone released by adipose tissue that lowers food intake and stimulates metabolic activity (29) . Serum leptin levels strongly correlate with body fat stores and with BMI (30) . Because leptin expression is affected by β-adrenergic stimulation through G s -coupled pathways (31), we measured serum leptin levels. In both male and female mice, serum leptin levels correlated with BMI ( Figure 3 ) and gonadal fat pad weights (data not shown) in both mutant and wildtype animals. It is therefore unlikely that the differences in lipid metabolism observed in +/p-and m-/+ mice are due to abnormal regulation of leptin levels.
We have shown that G s α protein expression in WAT membranes is normal in +/p-mice and reduced in m-/+ mice, consistent with G s α being paternally imprinted (silenced) in WAT (8) . We also showed that G s α mRNA levels in BAT are reduced only in m-/+ mice, consistent with paternal imprinting of G s α in BAT as well. We now measured G s α protein in BAT membranes by immunoblotting. G s α protein levels were normal in +/p-mice (101 ± 14% of wild-type; n = 5 pairs) and reduced in m-/+ mice (40 ± 7% of wildtype; n = 5 pairs; P = 0.001 versus wild-type). In contrast, G s α is not imprinted in skeletal muscle, as G s α mRNA was similarly reduced in +/p-and m-/+ mice (+/pmice: 45 ± 6% of wild-type; m-/+ mice 55 ± 6% of wildtype; n = 5 pairs for each).
Food intake and energy metabolism studies. Differences in fat accumulation reflect differences in either energy (food) intake, energy expenditure, or both. Food intake was normal in both m-/+ and +/p-mice (Figure 4a ) and therefore cannot account for the opposite effects on adiposity. In fact, there is a trend toward increased food intake in +/p-mice and decreased food intake in m-/+ mice. We next examined resting metabolic rate (RMR) by indirect calorimetry. Initially, we examined the RMR of older mice over a 24-hour period at normal ambient temperature (21°C). RMR in +/p-mice was 23% greater than, and RMR in m-/+ mice was 28% less than, that of controls (Figure 4b) . In both cases, the differences were significant. These data suggest that +/p-mice are hypermetabolic and that m-/+ mice are hypometabolic. Simultaneously measured total and ambulating activities were significantly increased in +/p-mice (Figure 4c ). In contrast, locomotor activity was decreased in m-/+ mice (Figure 4c ; significant only for ambulating activity). These opposite changes in activity should lead to even greater changes in total energy expenditure in +/pand m-/+ mice.
We next examined metabolic rate before and after maximal β 3 -adrenergic stimulation (CL316243) at thermoneutrality (30°C; refs. 32 and 33) . The RMR at thermoneutrality reflects the metabolic activity of lean body mass, with minimal sympathetic stimulation of adipose tissue (34) . Metabolic activity in response to CL316243 presumably represents the maximal metabolic response of adipose tissue, as mice with no adipose tissue do not increase their metabolic rate in response to CL316243 (O. Gavrilova, unpublished observations). The +/p-, m-/+, and wild-type mice had similar metabolic rates after administration of CL316243 (Figure 4d ), indicating that all are capable of achieving a similar maximal metabolic rate. However, at 30°C, +/p-mice had a higher RMR than did either m-/+ or wild-type mice, both in terms of absolute rate of oxygen consumption and in terms of percent of maximal stimulation (71% for +/pmice versus 55% for wild-type littermates; P < 0.01). The
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The +/p-mice are both hypermetabolic and more active, and this plausibly explains why these mice have markedly decreased body fat. Although older m-/+ mice were hypometabolic at 21°C, the RMRs of younger m-/+ and wild-type mice are similar at 30°C (Figure 4 , d and e; 30°C; no CL316243). The low metabolic rate at 21°C was confirmed in a group of younger m+/-mice (Figure 4e ; 21°C; no CL316243). When compared with the RMR at 30°C, lowering the environmental temperature caused a significant increase in RMRs in both m-/+ and wild-type mice as a result of increased sympathetic stimulation, but the increase in m-/+ mice was not as great as that in wild-type mice. Therefore, relative to wild-type mice, m-/+ mice are both hypometabolic and less active, and this is most likely the reason that these mice have increased fat stores. G s α is required for sympathetic stimulation of lipolysis in WAT and thermogenesis in BAT. Therefore decreased G s α expression in adipose tissue might lead to decreased β-adrenergic sensitivity and decreased RMR in m-/+ mice. To examine directly the responsiveness of adipose tissue to β-adrenergic stimulation in vivo, oxygen consumption was measured after administration of various doses of CL316243 at 30°C (Figure 4e ). The dose-response curves for m-/+ and wild-type littermates were virtually identical, even at doses that produced metabolic rates similar to those observed at 21°C in the absence of β 3 agonist (Figure  4e ; 21°C; no CL316243). These results indicate that adipose tissue in m-/+ mice is normally responsive to β-adrenergic stimulation and that the decreased metabolic rate at 21°C is unlikely to be caused by resistance of adipose tissue to sympathetic stimulation.
To examine further the physiological response of adipose tissue to β 3 -adrenergic stimulation in m-/+ mice, we measured the rise in serum glycerol and FFA after a maximal dose of CL316243 to fasted mice. Glycerol and FFA concentrations were similar in m-/+ mice and their wild-type littermates at baseline and at 15 minutes and 2 hours after CL316243 administration (Figure 4f and data not shown), consistent with a normal lipolytic response to maximal β 3 -adrenergic stimulation. The responses of serum insulin and glucose levels to CL316243 were also normal in m-/+ mice, with serum insulin levels increasing markedly and serum glucose decreasing (data not shown). Similar results for serum glycerol, FFA, insulin, and glucose were obtained in the fed state (data not shown).
Urinary catecholamines and their metabolites. Because G s α expression in adipose tissue of +/p-mice is normal and the decrease in G s α expression in adipose tissue of m-/+ mice is apparently insufficient to produce resistance to sympathetic stimulation, we next tried to determine whether the opposite effects in energy metabolism between +/p-and m-/+ mice result from increased and decreased sympathetic input to adipose tissue, respectively. To look for differences in sympathetic activity in +/p-and m-/+ mice, we collected urine for 72 hours and measured urinary norepinephrine (NE), epinephrine (EPI), and dihydroxyphenylalanine (DOPA), as well as dihydroxyphenylglycol (DHPG) and dihydroxyphenylacetic acid (DOPAC), the deaminated metabolites of NE and dopamine, respectively (Table 3) . To correct for differences in collection and lean body mass, all were normalized to urine creatinine. These measurements provide a measure of total sympathetic activity and do not assess the sympathetic input to specific tissues, such as adipose tissue. NE, which primarily reflects neural sympathetic activity (35) , was increased by approximately 20% in +/pmice and decreased by approximately 20% in m-/+ mice, which correlates well with the reciprocal changes in metabolic rate observed in these 2 groups of mice. The differences in urinary NE levels between +/p-and m-/+ mice were statistically significant (P < 0.01; Table 3 ). DHPG is formed primarily by presynaptic reuptake and deamination of NE by monoamine oxidase. Consistent with the results for NE, there is a tendency for DHPG lev- els to be increased in +/p-mice and decreased in m-/+, although these results are more difficult to interpret, as there is significant disparity between the 2 wild-type groups. The results for NE and DHPG suggest increased overall neural sympathetic activity in +/p-and decreased activity in m-/+ mice. In contrast, EPI, which primarily reflects adrenomedullary activity (35) , is similar in mutant and wild-type mice. DOPA, a precursor for NE and EPI, is the product of tyrosine hydroxylase, the ratelimiting enzyme in catecholamine biosynthesis. Urinary DOPA is elevated in both m-/+ and +/p-mice, suggesting that the differences in sympathetic activity (reflected by NE) are not due to changes in catecholamine biosynthesis. DOPAC, a neuronal metabolite of DA, is similar in all groups. In summary, the results of urinary catecholamines suggest that adrenomedullary activity is unaffected, whereas neural sympathetic activity is increased in +/p-mice and decreased in m-/+ mice. These changes in sympathetic activity might lead to the increased and decreased locomotor activity observed in +/p-and m-/+ mice, respectively.
Discussion
In this article, we show that a heterozygous mutation in Gnas leads to obesity when present within the maternal allele and to leanness when present within the paternal allele. In terms of energy metabolism, m-/+ and +/p-mice are distinct mouse models with opposite effects on both activity levels and resting energy expenditure, which are reduced in m-/+ mice and elevated in +/p-mice. BAT generates heat upon stimulation by local sympathetic nerves. Chronic stimulation of BAT increases its capacity for thermogenesis by increasing UCP1 expression, the number of mitochondria per cell, and cell number (26, 27) . BAT is important for 2 functions: maintenance of body temperature by nonshivering thermogenesis, and maintenance of energy balance (and therefore normal weight) by diet-induced thermogenesis, in which excess caloric intake is dissipated as heat (27, 36) . The role of BAT in the maintenance of energy balance is underscored by the fact that mice with partial ablation of BAT (the UCP1-DTA model) develop obesity (37) . Understimulation of BAT in m-/+ mice is suggested by its histological appearance and decreased UCP1 expression. Similar changes in BAT are observed in mice lacking leptin (38) , UCP1 (39) , or the catecholamines NE and EPI (40) . Although partial ablation of BAT leads to hyperphagia (37, 41) , suggesting that BAT might have a role in regulating food intake, the obesity in m-/+ mice is not associated with hyperphagia. RMR in m-/+ mice is normal at thermoneutrality (30°C), a condition associated with minimal sympathetic stimulation of BAT (34) . However, at a temperature below thermoneutrality (21°C), m-/+ mice did not raise their energy expenditure to the same extent as wild-type mice. This is reminiscent of UCP1-DTA mice, which develop obesity at room temperature but not at thermoneutrality (42) . It seemed likely that the reduced RMR at 21°C in m-/+ mice is caused by decreased responsiveness of adipose tissue to sympathetic stimulation due to a lower abundance of G s α. However, the physiological response of adipose tissue to β 3 -adrenergic stimulation appears to be normal in these mice, suggesting that either G s α is not rate limiting for signal transduction or that the response requires small changes in intracellular cAMP, as is the case for other cAMP-dependent cellular responses (43) (44) (45) (46) . Although our studies do not rule out the possibility that adipose tissue in m-/+ mice is resistant to β 1 -or β 2 -adrenergic stimulation, we believe that this is unlikely. In skeletal muscle, the lack of imprinting of G s α in skeletal muscle (leading to similar G s α expression levels) and normal UCP3 expression in m-/+ and +/p-mice suggest that the observed differences in RMR are not due to differences in the metabolic responsiveness of skeletal muscle to sympathetic stimulation. However, the observed changes in locomotor activity in m-/+ and +/p-mice should lead to even greater changes in total energy expenditure. These results and the decreased urinary NE excretion suggest that decreased RMR in m-/+ mice at 21°C is due to decreased sympathetic input. However, urinary catecholamines are an integrated measure of sympathetic activity throughout the organism and may not reflect the level of sympathetic activity within specific tissues important for energy metabolism. Definitive assessment of tissue-specific sympathetic activity will require direct measurement of catecholamine levels and turnover rates within specific tissues.
Like m-/+ mice, humans with mutations within the maternal allele of GNAS1 (PHP Ia) develop obesity (3). The physiological mechanisms causing obesity in these patients have not been defined. β-adrenergic stimulation of adenylyl cyclase is decreased in WAT plasma membranes from patients with PHP Ia, and patients with PHP Ia have decreased serum concentrations of FFAs (47) . Thus, it was suggested that the obesity in PHP Ia is due to resistance of adipose tissue to sympathetic stimulation. Alternatively, our results in m-/+ mice suggest that decreased lipolytic activity in adipose tissue of patients with PHP Ia could result from decreased sympathetic stimulation. Sympathetic activity in patients with PHP Ia needs to be directly assessed.
In contrast to m-/+ mice, +/p-mice have the reverse phenotype with markedly decreased lipid stores in WAT and increased RMR and activity levels. In 2 transgenic models, overactivity of the cAMP-generating system in adipose tissue leads to increased metabolic activation and decreased lipid stores (48, 49) . Similarly, adipose tissue in +/p-mice appears overstimulated based on the histological appearance of the BAT and WAT and increased UCP1 expression in BAT. G s α expression in adipose tissue is normal in these mice. Thus, the sensitivity of adipose tissue to sympathetic stimulation is unlikely to be affected. Our data are most consistent with increased sympathetic activity in +/p-mice. The +/p-mouse model does not mimic the analogous human disease, as patients with PPHP tend to have obesity rather than decreased fat mass. The disparate findings between +/p-mice and patients with PPHP might be the result of species-specific differences in the role of BAT in energy balance, in the importance of specific Gnas gene products, and/or in social and environmental factors.
We have shown that a single genetic defect within the maternal or paternal Gnas allele leads to opposite effects on energy metabolism. If the relevant underlying defect is dysregulation of sympathetic pathways in the central nervous system, then opposite effects on sympathetic activation might be caused by disruption 1,400 ± 800 780 ± 510 1,200 ± 600 DOPAC 5,400 ± 500 7,600 ± 2400 6,400 ± 700 5,700 ± 1600
A Measurements in 3-to 4-month-old male +/p-and m-/+ mice and paired wild-type littermates (5 pairs of each) expressed as pmol/mg creatinine (mean ± SEM). B P < 0.01 versus +/p-mice. C P < 0.05 versus-type littermates.
of maternal-and paternal-specific Gnas gene products in m-/+ and +/p-mice, respectively. G s α deficiency in specific regions of the central nervous system due to region-specific imprinting might lead to decreased sympathetic activity in m-/+ mice. Disruption of alternative Gnas products could also play a role in dysregulation of energy metabolism. NESP55 is a maternal-specific Gnas gene product expressed primarily in the adrenal medulla and brain (16, 17) . However, NESP55 probably does not play a role in the m-/+ phenotype, as the exon 2 insertion does not disrupt the NESP55 coding region, and preliminary results suggest that adrenal expression of NESP55 mRNA is intact in m-/+ mice (S. Yu and L.S. Weinstein, unpublished data). Moreover, obesity develops in patients with PHP Ia in whom GNAS1 missense mutations should not affect NESP55 expression (25) . It is also possible that the +/p-phenotype results from loss of expression of the paternal-specific Gnas gene product XLαs, which is primarily expressed in the central nervous system (13) . Specific knockouts will help define the role of these alternative Gnas products in the maternal and paternal GsKO phenotypes.
It has been proposed that genomic imprinting is the result of conflicting parental goals, whereby it is in the father's interest for his offspring to gain the most resources, whereas it is in the mother's interest to conserve resources so all of her offspring can survive (54) . This model predicts that genes contributed by the father would promote growth, whereas those contributed by the mother would inhibit growth. This has been shown for some imprinted genes, such as Igf2 and Igf2r (55-57), but has not been found consistently in all imprinted genes (58, 59) . For most of these genes, the major effect is on prenatal growth. GsKO mice confirm and extend this model to postnatal growth, as disruption of the paternal allele leads to decreased prenatal growth, failure to suckle at birth, and markedly reduced accumulation of energy stores postnatally, whereas disruption of the maternal allele leads to opposite effects.
